IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.460
EU - Europa 7.339
AS - Asia 2.200
SA - Sud America 15
OC - Oceania 13
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 9
Totale 18.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.421
IE - Irlanda 2.085
SE - Svezia 1.676
CN - Cina 1.078
IT - Italia 1.000
SG - Singapore 867
UA - Ucraina 864
DE - Germania 670
FI - Finlandia 382
GB - Regno Unito 243
IN - India 180
PL - Polonia 158
FR - Francia 87
BE - Belgio 53
NL - Olanda 35
RU - Federazione Russa 35
CA - Canada 34
VN - Vietnam 19
ID - Indonesia 16
AU - Australia 11
TR - Turchia 11
AT - Austria 10
CL - Cile 9
CH - Svizzera 7
CZ - Repubblica Ceca 6
ES - Italia 6
EU - Europa 6
BR - Brasile 5
IR - Iran 5
JP - Giappone 5
MX - Messico 5
AL - Albania 4
EG - Egitto 4
RO - Romania 4
HK - Hong Kong 3
IL - Israele 3
LT - Lituania 3
PH - Filippine 3
A1 - Anonimo 2
ET - Etiopia 2
GR - Grecia 2
KR - Corea 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 18.045
Salva come PNG Salva come JPEG
Città #
Dublin 2.082
Jacksonville 1.747
Chandler 1.522
Nyköping 751
Singapore 676
Beijing 517
Ashburn 409
Princeton 400
Cambridge 361
Dearborn 358
Des Moines 277
Medford 247
Boardman 219
Ann Arbor 194
Messina 189
Warsaw 156
Hyderabad 130
Wilmington 123
New York 110
Lancaster 93
Houston 84
Woodbridge 77
Jinan 75
Seattle 65
San Mateo 64
Shenyang 64
Bremen 62
Brussels 53
Los Angeles 52
Milan 50
Nanjing 47
Pune 43
Rome 37
Hebei 34
Haikou 32
Hangzhou 32
Norwalk 29
Tianjin 29
Zhengzhou 27
Helsinki 26
Ningbo 26
Taizhou 26
Munich 23
Catania 22
Washington 20
Guangzhou 19
Dong Ket 18
Ottawa 18
Changsha 17
Nanchang 16
Fuzhou 15
Jiaxing 15
Jakarta 14
Saint Petersburg 14
Falls Church 12
Verona 11
Auburn Hills 10
Taiyuan 10
Vienna 10
Bari 9
Clearwater 9
Palermo 9
Paternò 9
Turin 9
Kastamonu 8
Paris 8
Tappahannock 8
Bologna 7
Fiumefreddo Di Sicilia 7
Naples 7
Strasbourg 7
Urbino 7
Brno 6
Lanzhou 6
Santa Clara 6
Sarno 6
Torino 6
Amsterdam 5
Fairfield 5
Florence 5
Genova 5
London 5
Napoli 5
Perugia 5
Redmond 5
Riva 5
Salerno 5
Augusta 4
Brescia 4
Cefalù 4
Enschede 4
Frankfurt am Main 4
Hanover 4
Hefei 4
Mascali 4
Massa 4
Novokuznetsk 4
Philadelphia 4
Redwood City 4
Sesto San Giovanni 4
Totale 12.095
Salva come PNG Salva come JPEG
Nome #
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 300
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 255
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 130
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 115
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 105
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 102
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 98
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 98
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 96
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 95
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 93
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 89
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 88
Interazione farmacocinetica tra mirtazapina e clozapina in pazienti schizofrenici. 85
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 82
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 79
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 78
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 77
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 77
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 76
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 76
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 75
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 75
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 74
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 74
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study 72
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 71
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 71
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 71
“Effect of valproic acid on plasma concentrations of olanzapine in patients with psychiatric disorders” 70
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 70
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics 70
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 70
n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell (BAFF) transgenic mice 69
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 69
"Valproic acid-amitriptyline interaction in man 69
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 69
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? 69
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. 68
Impiego del Risperidone nel disturbo autistico: valutazioni farmacocinetiche e cliniche 67
INFLUENCE OF CYP2C9 POLYMORPHISM IN LUNG CANCER SUSCEPTIBILITY 66
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 66
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 66
Impiego clinico del Risperidone in età evolutiva: variazioni farmacocinetiche e cliniche 65
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 65
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 65
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 64
Safety and tolerability of psychotropic medications in childhood: preliminary data of a pharmacovigilance study 64
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 64
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 64
Pharmacogenomics in Psychiatry 64
The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia 63
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 63
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 63
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 63
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 63
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 63
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 63
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 63
Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents 63
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 62
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 62
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 62
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 62
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone 61
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 61
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 61
Evaluation of putative cytotoxic activity of crude extracts from Onopordum acanthium leaves and Spartium junceum flowers against the U-373 glioblastoma cell line. 61
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 61
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 61
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 60
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 60
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 60
Off-label use of second-generation antipsychotics 59
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 59
Fase prodromica della schizofrenia: prospettive diagnostiche ed opportunità terapeutiche 59
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 59
Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder 58
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia 58
ADJUNCTIVE FLUOXETINE IN THE TREATMENT OF NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIC PATIENTS 58
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 58
Uso dell’aripiprazolo in bambini con Multiple-complex Developmental Disorder. 58
Systemic cardiorespiratory effects induced by doxofylline 58
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 58
ECG parameters in children and adolescents treated with aripiprazole and risperidone 58
Metabolic drug interactions with newer antipsychotics: a comparative review. 57
Profilo di tollerabilità degli antipsicotici atipici e degli inibitori selettivi della ricaptazione della serotonina in età evolutiva. 57
Impiego clinico dell'olanzapina in età evolutiva 57
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 57
Short-term memory loss associated with rosuvastatin. 57
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 57
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease 55
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 55
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 55
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 55
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 55
Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study 54
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 54
Preventing drug interactions with antidepressants in the elderly 54
Livelli serici di prolattina in corso di trattamento con risperidone o olanzapina in bambini ed adolescenti con patologie psichiatriche. 54
Totale 7.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.021 0 0 0 0 16 378 365 312 56 314 547 33
2020/20212.408 282 22 545 138 156 299 56 243 56 338 133 140
2021/20222.228 27 225 31 78 50 23 133 114 83 446 293 725
2022/20235.906 509 412 218 480 521 543 52 347 2.554 28 176 66
2023/20241.672 121 246 109 169 168 338 70 102 26 164 19 140
2024/20251.123 96 95 156 401 375 0 0 0 0 0 0 0
Totale 18.404